Home
News
Create
Screeners
Insights
Aspira Pathlab
59.
00
-59.00
(-100.00%)
Market Cap
₹60.70 Cr
PE Ratio
25.32
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
-100.00%
1M
-100.00%
6M
-100.00%
1Y
-100.00%
5Y
-100.00%
View Company Insights
Latest news about Aspira Pathlab
Aspira Pathlab Reports Q3FY26 Net Loss of ₹156.12 Lakhs Against Prior Year Profit
7 days ago
Aspira Pathlab & Diagnostics Limited reported a net loss of ₹156.12 lakhs for Q3FY26 against a profit of ₹37.66 lakhs in Q3FY25, with revenue declining 5.33% to ₹511.88 lakhs. For nine months FY26, the company maintained profitability at ₹74.03 lakhs despite a 45.17% decline from ₹135.02 lakhs in the previous year. The Board approved a ₹5 crore related party transaction with Yashraj Research Foundation subject to member approval.
Aspira Pathlab Submits Quarterly Compliance Certificate for Q3FY26 Under SEBI Regulations
Jan 07, 2026
Aspira Pathlab & Diagnostics Limited Announces Demise of Independent Director Dr. Alaka Keshav Deshpande
Jan 02, 2026
Aspira Pathlab Reports Q2 Loss, Appoints New Independent Director
Nov 13, 2025
Aspira Pathlab & Diagnostics Receives Open Offer for 26% Stake at Rs. 55 Per Share
Sep 26, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation